Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46,603,818
-$7,733,076 QoQ
Shares Held
50,669
+0.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. LLY ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,603,818 | 50,669 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,336,894 | 50,561 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,861,879 | 50,933 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $37,856,308 | 48,563 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $38,992,856 | 47,212 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,515,340 | 48,595 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $43,918,696 | 49,573 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,882,395 | 49,573 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $35,418,956 | 45,528 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $25,242,178 | 43,303 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $21,840,773 | 40,662 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,126,873 | 40,784 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $16,488,276 | 48,012 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $16,843,268 | 46,040 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,214,464 | 43,960 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,852,396 | 42,724 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $9,077,926 | 31,700 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $11,099,346 | 40,183 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,348,527 | 36,133 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,840,631 | 34,161 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,855,870 | 31,345 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $5,162,450 | 30,576 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,940,461 | 33,377 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,155,249 | 31,400 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,386,397 | 17,203 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||